Search Results for: "Clinic Roundup"
-
Pharma: Clinic Roundup
In the 428-patient, randomized, double-blind, active- and placebo-controlled trial, both the 18-mg and 35-mg doses of the nonsteroidal anti-inflammatory drug met the primary objective of significant improvement in pain relief, measured by the combined differences in pain intensity at intervals over 48 hours using a visual analogue scaleBioWorld Today | Friday, June 22, 2012 -
Clinic Roundup
The multi-center, double-blind study will be conducted on 75 patients with Type 2 diabetes mellitus and albuminuriaBioWorld Today | Wednesday, June 20, 2012 -
Clinic Roundup
The 18-month, double-blind, placebo-controlled study will be followed by an open-label extension study, with all patients taking RP103 for up to an additional 18 monthsBioWorld Today | Tuesday, June 19, 2012 -
Clinic Roundup
The randomized double-blind, placebo-controlled, dose-ranging study (JADA) involved 301 patients with active RA on stable doses of methotrexateBioWorld Today | Monday, June 11, 2012 -
Clinic Roundup
The randomized, double-blind, placebo-controlled global study will seek to demonstrate a benefit in overall survival in a chemotherapy-naive patient populationBioWorld Today | Thursday, June 7, 2012 -
Clinic Roundup
The double-blind, crossover-controlled Phase II study will compare tivozanib with sunitinib in about 160 patients...The double-blind, placebo-controlled study, being conducted under an FDA special protocol assessment, is designed to enroll more than 1,000 patients with resected Stage IIb, IIc or III melanoma in Europe and the U.S. The biotech expects to reach the recurrence-free survival endpoint by mid-2016 and file an early biologic license applicationBioWorld Today | Tuesday, June 5, 2012 -
Clinic Roundup
Oxygen Biotherapeutics Inc., of Morrisville, N.C., said its randomized, double-blind, placebo-controlled study of the efficacy of Dermacyte for histamine-induced pruritis showed that the drug produced a larger reduction in Visual Analogue Scale scores after standard histamine skin prick than placeboBioWorld Today | Friday, June 1, 2012 -
Clinic Roundup
The double-blind, multinational, placebo-controlled study evaluated ulimorelin in accelerating GI recovery in patients who had undergone partial bowel resectionBioWorld Today | Wednesday, May 30, 2012 -
Clinic Roundup
The international, randomized, double-blind, placebo-controlled trial, conducted by Amgen Inc., of Thousand Oaks, Calif., is testing an intravenous formulation of omecamtiv mecarbil in patients with left ventricular systolic dysfunction who are hospitalized with acute heart failureBioWorld Today | Friday, May 25, 2012 -
Clinic Roundup
Pulmatrix Inc., of Lexington, Mass., reported results from a randomized, double-blind crossover trial of seven mild atopic steroid-naïve asthmatic patients who inhaled iCALM (inhaled cationic airway lining modulatory therapy), showing that the product attenuated allergen-induced bronchitis in susceptible asthmaticsBioWorld Today | Tuesday, May 22, 2012 -
Clinic Roundup
The 36-month randomized, multicenter, double-blind, placebo-controlled trial will include at least 200 patients in 16 centers in Europe and Israel...The double-blind, closed-label, placebo-controlled trial is being conducted at 20 sites in five countries across EuropeBioWorld Today | Friday, May 18, 2012 -
Pharma: Clinic Roundup
Ltd., of Osaka, Japan, reported top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal Phase III trialBioWorld Today | Monday, May 14, 2012 -
Clinic Roundup
The randomized, double-blind, placebo-controlled trial will enroll about 96 healthy volunteers in the U.S. Besides investigating the safety, tolerability and pharmacokinetic profile of ACH-3102, the trial will assess single and multiple ascending oral doses for up to 28 days...In SUSTAIN, a 24-week, multi-centered, double-blind, randomized, parallel group, placebo controlled trial, all subjects received standard of care therapy including up to 40 mg Lipitor (atorvastatin, Pfizer) or 20 mg CrestorBioWorld Today | Thursday, May 10, 2012 -
Pharma: Clinic Roundup
They were randomized to active treatment or placebo for a six-month double-blind studyBioWorld Today | Tuesday, May 8, 2012 -
Clinic Roundup
The double-blind, placebo-controlled study explored a single ascending dosing of up to 1,800 mg, and 15-day multiple-dose regimens of twice-daily 600 mg and 800 mgBioWorld Today | Tuesday, April 24, 2012 -
Clinic Roundup
The results came from two identical Phase III randomized, double-blind, placebo-controlled studies of 421 patientsBioWorld Today | Thursday, April 19, 2012 -
Clinic Roundup
The randomized, double-blind, placebo-controlled trial will evaluate safety and efficacy of single-agent MORAb-004 with supportive care for progression-free survival in patients with chemo-refractory metastatic colorectal cancerBioWorld Today | Tuesday, April 17, 2012 -
Clinic Roundup
The company completed the 12-week, randomized, double-blind, placebo-controlled, Phase II trial at the end of 2011BioWorld Today | Thursday, April 12, 2012 -
Clinic Roundup
The trial was randomized and double-blind, comparing a one-time treatment with 20 intramuscular injections of ixmyelocel-T to placeboBioWorld Today | Friday, April 6, 2012 -
Clinic Roundup
The program includes an international, randomized, double-blind, placebo-controlled, parallel-group, two-year study in more than 5,000 postmenopausal women with osteoporosisBioWorld Today | Thursday, April 5, 2012
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.